Literature DB >> 19331210

Chronic lymphocytic leukaemia.

Jerina Boelens1, Sofie Lust, Barbara Vanhoecke, Fritz Offner.   

Abstract

Chronic lymphocytic leukaemia remains the most common adult leukaemia in Western countries. In this review we tried to give an overview of the important prognostic markers and the developments in this field. We also reflected about the accumulative character of the disease and the influence of the micro-environment on the CLL cell.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19331210

Source DB:  PubMed          Journal:  Anticancer Res        ISSN： 0250-7005            Impact factor:   2.480


  7 in total

Review 1.  When Glycosylation Meets Blood Cells: A Glance of the Aberrant Glycosylation in Hematological Malignancies.

Authors:  Huining Su; Mimi Wang; Xingchen Pang; Feng Guan; Xiang Li; Ying Cheng
Journal:  Rev Physiol Biochem Pharmacol       Date:  2021       Impact factor: 5.545

2.  Utility of laboratory tests in B-CLL patients in different clinical stages.

Authors:  Małgorzata Rusak; Joanna Osada; Joanna Pawlus; Joanna Chociej-Stypułkowska; Milena Dąbrowska; Janusz Kłoczko
Journal:  Int J Hematol       Date:  2011-05-28       Impact factor: 2.490

3.  Chronic lymphocytic leukemia-associated cholangiopathy.

Authors:  Jake Mann; Stefan Urbanski; Johan Lategan; Mark G Swain
Journal:  Can J Gastroenterol       Date:  2011-07       Impact factor: 3.522

4.  Bufalin Enhances Immune Responses in Leukemic Mice Through Enhancing Phagocytosis of Macrophage In Vivo.

Authors:  Yung-Luen Shih; Jiann-Shang Chou; Yung-Liang Chen; Shu-Ching Hsueh; Hsueh-Yu Chung; Mei-Hui Lee; Chao-Ping Chen; Ming-Zhe Lee; Hsin-Tu Hou; Hsu-Feng Lu; Kuo-Wei Chen; Jing-Gung Chung
Journal:  In Vivo       Date:  2018 Sep-Oct       Impact factor: 2.155

Review 5.  Ibrutinib: a review of its use in patients with mantle cell lymphoma or chronic lymphocytic leukaemia.

Authors:  Esther S Kim; Sohita Dhillon
Journal:  Drugs       Date:  2015-05       Impact factor: 9.546

6.  Case Report of Unexpectedly Long Survival of Patient With Chronic Lymphocytic Leukemia: Why Integrative Methods Matter.

Authors:  Gregory Haskin; Mikhail Kogan
Journal:  Integr Med (Encinitas)       Date:  2018-02

7.  Spontaneous Immunity Against the Receptor Tyrosine Kinase ROR1 in Patients with Chronic Lymphocytic Leukemia.

Authors:  Mohammad Hojjat-Farsangi; Mahmood Jeddi-Tehrani; Amir Hossein Daneshmanesh; Fariba Mozaffari; Ali Moshfegh; Lotta Hansson; Seyed Mohsen Razavi; Ramazan Ali Sharifian; Hodjattallah Rabbani; Anders Österborg; Håkan Mellstedt; Fazel Shokri
Journal:  PLoS One       Date:  2015-11-12       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.